BlackRock’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$60M Buy
4,007,296
+434,622
+12% +$6.51M ﹤0.01% 2312
2025
Q1
$57.6M Buy
3,572,674
+173,083
+5% +$2.79M ﹤0.01% 2281
2024
Q4
$79.1M Buy
3,399,591
+736,444
+28% +$17.1M ﹤0.01% 2184
2024
Q3
$78.3M Buy
2,663,147
+259,706
+11% +$7.64M ﹤0.01% 2193
2024
Q2
$56.5M Buy
2,403,441
+1,846,750
+332% +$43.4M ﹤0.01% 2309
2024
Q1
$21.1M Buy
556,691
+536,929
+2,717% +$20.4M ﹤0.01% 2909
2023
Q4
$425K Sell
19,762
-6
-0% -$129 ﹤0.01% 4386
2023
Q3
$242K Sell
19,768
-1,388
-7% -$17K ﹤0.01% 4562
2023
Q2
$238K Sell
21,156
-4,790
-18% -$53.9K ﹤0.01% 4603
2023
Q1
$188K Buy
25,946
+108
+0.4% +$783 ﹤0.01% 4709
2022
Q4
$291K Sell
25,838
-15,469
-37% -$174K ﹤0.01% 4663
2022
Q3
$542K Sell
41,307
-1,477
-3% -$19.4K ﹤0.01% 4615
2022
Q2
$540K Sell
42,784
-74,088
-63% -$935K ﹤0.01% 4664
2022
Q1
$6.72M Sell
116,872
-3,067
-3% -$176K ﹤0.01% 3714
2021
Q4
$14.2M Buy
119,939
+583
+0.5% +$69.2K ﹤0.01% 3408
2021
Q3
$23.7M Sell
119,356
-4,799
-4% -$954K ﹤0.01% 3116
2021
Q2
$21.6M Sell
124,155
-9,857
-7% -$1.72M ﹤0.01% 3195
2021
Q1
$26.5M Buy
134,012
+4,413
+3% +$874K ﹤0.01% 2982
2020
Q4
$25.5M Buy
129,599
+4,488
+4% +$883K ﹤0.01% 2827
2020
Q3
$22.2M Sell
125,111
-3,562
-3% -$631K ﹤0.01% 2737
2020
Q2
$29.8M Buy
128,673
+52,314
+69% +$12.1M ﹤0.01% 2550
2020
Q1
$8.9M Sell
76,359
-530
-0.7% -$61.8K ﹤0.01% 3010
2019
Q4
$14.7M Buy
76,889
+788
+1% +$151K ﹤0.01% 3012
2019
Q3
$14.6M Buy
76,101
+1,912
+3% +$368K ﹤0.01% 2967
2019
Q2
$12.7M Buy
74,189
+14,573
+24% +$2.5M ﹤0.01% 3076
2019
Q1
$12M Buy
59,616
+7,454
+14% +$1.5M ﹤0.01% 3007
2018
Q4
$9.77M Buy
52,162
+11,002
+27% +$2.06M ﹤0.01% 3081
2018
Q3
$9.85M Buy
41,160
+8,260
+25% +$1.98M ﹤0.01% 3213
2018
Q2
$8.7M Buy
32,900
+31,920
+3,257% +$8.44M ﹤0.01% 3276
2018
Q1
$243K Buy
980
+102
+12% +$25.3K ﹤0.01% 4123
2017
Q4
$119K Buy
878
+141
+19% +$19.1K ﹤0.01% 4252
2017
Q3
$91K Sell
737
-16
-2% -$1.98K ﹤0.01% 4309
2017
Q2
$72K Buy
753
+147
+24% +$14.1K ﹤0.01% 4393
2017
Q1
$113K Buy
+606
New +$113K ﹤0.01% 4252